SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-289487
Filing Date
2022-11-21
Accepted
2022-11-21 07:00:55
Documents
16
Period of Report
2022-11-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d284218d8k.htm   iXBRL 8-K 34683
2 EX-99.1 d284218dex991.htm EX-99.1 21998
6 GRAPHIC g284218g01a02.jpg GRAPHIC 14612
7 GRAPHIC g284218g63n72.jpg GRAPHIC 1468
8 GRAPHIC g284218g80o96.jpg GRAPHIC 4305
  Complete submission text file 0001193125-22-289487.txt   212616

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20221118.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20221118_lab.xml EX-101.LAB 17168
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20221118_pre.xml EX-101.PRE 10793
10 EXTRACTED XBRL INSTANCE DOCUMENT d284218d8k_htm.xml XML 3367
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 221403462
SIC: 2834 Pharmaceutical Preparations